Table 3.
Analysis of IGF-II-mRNA and AFP-mRNA in peripheral blood of patients with different liver diseases or non-liver tumors
| Groups | n |
IGF-II mRNA |
AFP mRNA |
Both |
|||
| Positive | % | Positive | % | Positive | % | ||
| HCC | 111 | 38 | 34.2 | 58 | 52.3 | 68 | 61.3 |
| LC | 25 | 0 | 0b | 5 | 20.0b | 5 | 20.0b |
| CH | 30 | 0 | 0b | 2 | 6.7b | 2 | 6.7b |
| AH | 30 | 0 | 0b | 0 | 0b | 0 | 0b |
| ET | 25 | 0 | 0b | 0 | 0b | 0 | 0b |
| NC | 25 | 0 | 0b | 0 | 0b | 0 | 0b |
b
P<0.01 vs the hepatocellular carcinoma group. HCC: hepatocellular carcinoma; LC: liver cirrhosis; CH: chronic hepatitis; AH: acute hepatitis; ET: extrahepatic tumor; NC: normal control.